THOMPSON DAVIS & CO., INC. - CANCER GENETICS INC ownership

CANCER GENETICS INC's ticker is CGIXXXXX and the CUSIP is 13739U104. A total of 26 filers reported holding CANCER GENETICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of CANCER GENETICS INC
ValueSharesWeighting
Q3 2018$1,0005000.0%0.00%
Q2 2018$0
-100.0%
5000.0%0.00%
-100.0%
Q1 2018$1,0000.0%5000.0%0.00%
+50.0%
Q4 2017$1,000
-99.2%
500
-98.9%
0.00%
-99.1%
Q3 2017$127,000
-71.1%
46,975
-57.8%
0.22%
-68.2%
Q2 2017$440,000
+5400.0%
111,300
+5465.0%
0.71%
+6327.3%
Q1 2017$8,0002,0000.01%
Other shareholders
CANCER GENETICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,391,607$1,239,0000.75%
PERKINS CAPITAL MANAGEMENT INC 1,004,550$894,0000.64%
Fairbanks Capital Management, Inc. 234,170$208,0000.24%
DIKER MANAGEMENT LLC 64,365$57,0000.02%
Granahan Investment Management 276,417$246,0000.02%
WEDBUSH SECURITIES INC 52,310$47,0000.01%
Court Place Advisors, LLC 10,000$9,0000.00%
SeaCrest Wealth Management, LLC 11,000$10,0000.00%
Renaissance Technologies 1,068,700$1,317,0000.00%
PANAGORA ASSET MANAGEMENT INC 43,664$39,0000.00%
View complete list of CANCER GENETICS INC shareholders